PolyNovo Limited
PolyNovo Limited CALZF Peers
See (CALZF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CALZF | $0.94 | +0.04% | 650.77M | 94.20 | $0.01 | N/A |
| SMMNY | $27.05 | +2.31% | 121.35B | 27.05 | $1.00 | +0.99% |
| SEMHF | $53.97 | +4.38% | 60.52B | 26.98 | $2.00 | +2.04% |
| RYLPF | $24.83 | +1.20% | 22.97B | 82.76 | $0.30 | N/A |
| SONVY | $63.30 | +0.68% | 18.86B | 27.52 | $2.30 | +1.79% |
| SONVF | $315.98 | +2.89% | 18.83B | 27.50 | $11.49 | +1.80% |
| SNNUF | $14.33 | +1.13% | 12.54B | 30.49 | $0.47 | +2.62% |
| CHEOY | $85.56 | +2.26% | 11.19B | 46.75 | $1.83 | +1.64% |
| CHEOF | $169.96 | N/A | 11.09B | 46.56 | $3.65 | +1.63% |
| WILYY | $18.78 | +0.86% | 8.00B | 18.59 | $1.01 | N/A |
Stock Comparison
CALZF vs SMMNY Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, SMMNY has a market cap of 121.35B. Regarding current trading prices, CALZF is priced at $0.94, while SMMNY trades at $27.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas SMMNY's P/E ratio is 27.05. In terms of profitability, CALZF's ROE is +0.07%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, CALZF is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs SEMHF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, SEMHF has a market cap of 60.52B. Regarding current trading prices, CALZF is priced at $0.94, while SEMHF trades at $53.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas SEMHF's P/E ratio is 26.98. In terms of profitability, CALZF's ROE is +0.07%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, CALZF is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs RYLPF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, RYLPF has a market cap of 22.97B. Regarding current trading prices, CALZF is priced at $0.94, while RYLPF trades at $24.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas RYLPF's P/E ratio is 82.76. In terms of profitability, CALZF's ROE is +0.07%, compared to RYLPF's ROE of -0.06%. Regarding short-term risk, CALZF is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs SONVY Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, SONVY has a market cap of 18.86B. Regarding current trading prices, CALZF is priced at $0.94, while SONVY trades at $63.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas SONVY's P/E ratio is 27.52. In terms of profitability, CALZF's ROE is +0.07%, compared to SONVY's ROE of +0.26%. Regarding short-term risk, CALZF is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs SONVF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, SONVF has a market cap of 18.83B. Regarding current trading prices, CALZF is priced at $0.94, while SONVF trades at $315.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas SONVF's P/E ratio is 27.50. In terms of profitability, CALZF's ROE is +0.07%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, CALZF is less volatile compared to SONVF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs SNNUF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, SNNUF has a market cap of 12.54B. Regarding current trading prices, CALZF is priced at $0.94, while SNNUF trades at $14.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas SNNUF's P/E ratio is 30.49. In terms of profitability, CALZF's ROE is +0.07%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, CALZF is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs CHEOY Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, CHEOY has a market cap of 11.19B. Regarding current trading prices, CALZF is priced at $0.94, while CHEOY trades at $85.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas CHEOY's P/E ratio is 46.75. In terms of profitability, CALZF's ROE is +0.07%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, CALZF is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs CHEOF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, CHEOF has a market cap of 11.09B. Regarding current trading prices, CALZF is priced at $0.94, while CHEOF trades at $169.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas CHEOF's P/E ratio is 46.56. In terms of profitability, CALZF's ROE is +0.07%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, CALZF is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs WILYY Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, WILYY has a market cap of 8.00B. Regarding current trading prices, CALZF is priced at $0.94, while WILYY trades at $18.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas WILYY's P/E ratio is 18.59. In terms of profitability, CALZF's ROE is +0.07%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, CALZF is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs WILLF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, WILLF has a market cap of 7.46B. Regarding current trading prices, CALZF is priced at $0.94, while WILLF trades at $36.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas WILLF's P/E ratio is 17.95. In terms of profitability, CALZF's ROE is +0.07%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, CALZF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs GNGBY Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, GNGBY has a market cap of 5.44B. Regarding current trading prices, CALZF is priced at $0.94, while GNGBY trades at $19.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas GNGBY's P/E ratio is 35.33. In terms of profitability, CALZF's ROE is +0.07%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, CALZF is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs GNGBF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, GNGBF has a market cap of 5.37B. Regarding current trading prices, CALZF is priced at $0.94, while GNGBF trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas GNGBF's P/E ratio is 37.70. In terms of profitability, CALZF's ROE is +0.07%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, CALZF is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs AMBFF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, AMBFF has a market cap of 4.13B. Regarding current trading prices, CALZF is priced at $0.94, while AMBFF trades at $17.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas AMBFF's P/E ratio is 84.76. In terms of profitability, CALZF's ROE is +0.07%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, CALZF is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs AMBBY Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, AMBBY has a market cap of 4.01B. Regarding current trading prices, CALZF is priced at $0.94, while AMBBY trades at $15.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas AMBBY's P/E ratio is 72.33. In terms of profitability, CALZF's ROE is +0.07%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, CALZF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs NHNKY Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, NHNKY has a market cap of 3.99B. Regarding current trading prices, CALZF is priced at $0.94, while NHNKY trades at $12.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas NHNKY's P/E ratio is 16.83. In terms of profitability, CALZF's ROE is +0.07%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, CALZF is more volatile compared to NHNKY. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs NHNKF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, NHNKF has a market cap of 2.48B. Regarding current trading prices, CALZF is priced at $0.94, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, CALZF's ROE is +0.07%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, CALZF is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs VTRLY Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, VTRLY has a market cap of 2.22B. Regarding current trading prices, CALZF is priced at $0.94, while VTRLY trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas VTRLY's P/E ratio is 43.13. In terms of profitability, CALZF's ROE is +0.07%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, CALZF is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs GNNDY Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, GNNDY has a market cap of 2.11B. Regarding current trading prices, CALZF is priced at $0.94, while GNNDY trades at $43.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas GNNDY's P/E ratio is 17.33. In terms of profitability, CALZF's ROE is +0.07%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, CALZF is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs STSEY Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, STSEY has a market cap of 2.04B. Regarding current trading prices, CALZF is priced at $0.94, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas STSEY's P/E ratio is 39.41. In terms of profitability, CALZF's ROE is +0.07%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, CALZF is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs SSII Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, SSII has a market cap of 1.96B. Regarding current trading prices, CALZF is priced at $0.94, while SSII trades at $10.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas SSII's P/E ratio is -92.27. In terms of profitability, CALZF's ROE is +0.07%, compared to SSII's ROE of -1.33%. Regarding short-term risk, CALZF is more volatile compared to SSII. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs GGNDF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, GGNDF has a market cap of 1.89B. Regarding current trading prices, CALZF is priced at $0.94, while GGNDF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas GGNDF's P/E ratio is 15.48. In terms of profitability, CALZF's ROE is +0.07%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, CALZF is less volatile compared to GGNDF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs OSSFF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, OSSFF has a market cap of 1.77B. Regarding current trading prices, CALZF is priced at $0.94, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, CALZF's ROE is +0.07%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, CALZF is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs DWRKF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, DWRKF has a market cap of 1.75B. Regarding current trading prices, CALZF is priced at $0.94, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, CALZF's ROE is +0.07%, compared to DWRKF's ROE of N/A. Regarding short-term risk, CALZF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs MCRPF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, MCRPF has a market cap of 1.73B. Regarding current trading prices, CALZF is priced at $0.94, while MCRPF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas MCRPF's P/E ratio is -7.77. In terms of profitability, CALZF's ROE is +0.07%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, CALZF is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs OSSUY Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, OSSUY has a market cap of 1.71B. Regarding current trading prices, CALZF is priced at $0.94, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, CALZF's ROE is +0.07%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, CALZF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs MEDGF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, MEDGF has a market cap of 1.67B. Regarding current trading prices, CALZF is priced at $0.94, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, CALZF's ROE is +0.07%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, CALZF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs DRWKF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, DRWKF has a market cap of 1.19B. Regarding current trading prices, CALZF is priced at $0.94, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas DRWKF's P/E ratio is 9.01. In terms of profitability, CALZF's ROE is +0.07%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, CALZF is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs XVIPF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, XVIPF has a market cap of 1.04B. Regarding current trading prices, CALZF is priced at $0.94, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas XVIPF's P/E ratio is 73.11. In terms of profitability, CALZF's ROE is +0.07%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, CALZF is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs LFTSF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, LFTSF has a market cap of 1.03B. Regarding current trading prices, CALZF is priced at $0.94, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, CALZF's ROE is +0.07%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, CALZF is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs DGWPF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, DGWPF has a market cap of 928.48M. Regarding current trading prices, CALZF is priced at $0.94, while DGWPF trades at $45.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas DGWPF's P/E ratio is 6.88. In terms of profitability, CALZF's ROE is +0.07%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, CALZF is less volatile compared to DGWPF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs ELEAF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, ELEAF has a market cap of 832.49M. Regarding current trading prices, CALZF is priced at $0.94, while ELEAF trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas ELEAF's P/E ratio is 12.08. In terms of profitability, CALZF's ROE is +0.07%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, CALZF is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs MDRSF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, MDRSF has a market cap of 826.63M. Regarding current trading prices, CALZF is priced at $0.94, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, CALZF's ROE is +0.07%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, CALZF is less volatile compared to MDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs AVMR Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, AVMR has a market cap of 494.15M. Regarding current trading prices, CALZF is priced at $0.94, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas AVMR's P/E ratio is -18.34. In terms of profitability, CALZF's ROE is +0.07%, compared to AVMR's ROE of -0.24%. Regarding short-term risk, CALZF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs CLVSF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, CLVSF has a market cap of 459.85M. Regarding current trading prices, CALZF is priced at $0.94, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, CALZF's ROE is +0.07%, compared to CLVSF's ROE of +0.18%. Regarding short-term risk, CALZF is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs HYBT Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, HYBT has a market cap of 361.36M. Regarding current trading prices, CALZF is priced at $0.94, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas HYBT's P/E ratio is N/A. In terms of profitability, CALZF's ROE is +0.07%, compared to HYBT's ROE of -0.02%. Regarding short-term risk, CALZF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs IOBCF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, IOBCF has a market cap of 326.64M. Regarding current trading prices, CALZF is priced at $0.94, while IOBCF trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas IOBCF's P/E ratio is 35.97. In terms of profitability, CALZF's ROE is +0.07%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, CALZF is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs EAPIF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, EAPIF has a market cap of 290.45M. Regarding current trading prices, CALZF is priced at $0.94, while EAPIF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas EAPIF's P/E ratio is -1.96. In terms of profitability, CALZF's ROE is +0.07%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, CALZF is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs CSSPF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, CSSPF has a market cap of 263.38M. Regarding current trading prices, CALZF is priced at $0.94, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, CALZF's ROE is +0.07%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, CALZF is more volatile compared to CSSPF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs CYBQY Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, CYBQY has a market cap of 261.21M. Regarding current trading prices, CALZF is priced at $0.94, while CYBQY trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas CYBQY's P/E ratio is -40.67. In terms of profitability, CALZF's ROE is +0.07%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, CALZF is less volatile compared to CYBQY. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs SNWV Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, SNWV has a market cap of 261.16M. Regarding current trading prices, CALZF is priced at $0.94, while SNWV trades at $30.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas SNWV's P/E ratio is -4.35. In terms of profitability, CALZF's ROE is +0.07%, compared to SNWV's ROE of +0.78%. Regarding short-term risk, CALZF is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs CLLKF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, CLLKF has a market cap of 252.12M. Regarding current trading prices, CALZF is priced at $0.94, while CLLKF trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas CLLKF's P/E ratio is -8.11. In terms of profitability, CALZF's ROE is +0.07%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, CALZF is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs BCCOY Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, BCCOY has a market cap of 249.26M. Regarding current trading prices, CALZF is priced at $0.94, while BCCOY trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas BCCOY's P/E ratio is -8.18. In terms of profitability, CALZF's ROE is +0.07%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, CALZF is less volatile compared to BCCOY. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs AVHHL Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, AVHHL has a market cap of 246.64M. Regarding current trading prices, CALZF is priced at $0.94, while AVHHL trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas AVHHL's P/E ratio is -4.75. In terms of profitability, CALZF's ROE is +0.07%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, CALZF is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs HTLZF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, HTLZF has a market cap of 245.15M. Regarding current trading prices, CALZF is priced at $0.94, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, CALZF's ROE is +0.07%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, CALZF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs IMPZY Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, IMPZY has a market cap of 199.95M. Regarding current trading prices, CALZF is priced at $0.94, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, CALZF's ROE is +0.07%, compared to IMPZY's ROE of -3.64%. Regarding short-term risk, CALZF is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs CYBQF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, CYBQF has a market cap of 173.46M. Regarding current trading prices, CALZF is priced at $0.94, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas CYBQF's P/E ratio is -43.33. In terms of profitability, CALZF's ROE is +0.07%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, CALZF is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs EKDHF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, EKDHF has a market cap of 162.48M. Regarding current trading prices, CALZF is priced at $0.94, while EKDHF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, CALZF's ROE is +0.07%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, CALZF is more volatile compared to EKDHF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs BRNHF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, BRNHF has a market cap of 161.85M. Regarding current trading prices, CALZF is priced at $0.94, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, CALZF's ROE is +0.07%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, CALZF is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs JMDMF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, JMDMF has a market cap of 154.98M. Regarding current trading prices, CALZF is priced at $0.94, while JMDMF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas JMDMF's P/E ratio is -43.25. In terms of profitability, CALZF's ROE is +0.07%, compared to JMDMF's ROE of N/A. Regarding short-term risk, CALZF is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs PXMBF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, PXMBF has a market cap of 151.86M. Regarding current trading prices, CALZF is priced at $0.94, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, CALZF's ROE is +0.07%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, CALZF is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs BRSYF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, BRSYF has a market cap of 128.39M. Regarding current trading prices, CALZF is priced at $0.94, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas BRSYF's P/E ratio is 37.78. In terms of profitability, CALZF's ROE is +0.07%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, CALZF is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs AMEUF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, AMEUF has a market cap of 120.50M. Regarding current trading prices, CALZF is priced at $0.94, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, CALZF's ROE is +0.07%, compared to AMEUF's ROE of -6.21%. Regarding short-term risk, CALZF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs VMTHF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, VMTHF has a market cap of 110.00M. Regarding current trading prices, CALZF is priced at $0.94, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas VMTHF's P/E ratio is -1.14. In terms of profitability, CALZF's ROE is +0.07%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, CALZF is more volatile compared to VMTHF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs FDMDF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, FDMDF has a market cap of 102.68M. Regarding current trading prices, CALZF is priced at $0.94, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, CALZF's ROE is +0.07%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, CALZF is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs RSHUF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, RSHUF has a market cap of 91.52M. Regarding current trading prices, CALZF is priced at $0.94, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, CALZF's ROE is +0.07%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, CALZF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs CKMTF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, CKMTF has a market cap of 85.19M. Regarding current trading prices, CALZF is priced at $0.94, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, CALZF's ROE is +0.07%, compared to CKMTF's ROE of +2.13%. Regarding short-term risk, CALZF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs SOMNF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, SOMNF has a market cap of 84.28M. Regarding current trading prices, CALZF is priced at $0.94, while SOMNF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas SOMNF's P/E ratio is -13.00. In terms of profitability, CALZF's ROE is +0.07%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, CALZF is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs DMTRF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, DMTRF has a market cap of 76.10M. Regarding current trading prices, CALZF is priced at $0.94, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, CALZF's ROE is +0.07%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, CALZF is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs IPDQF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, IPDQF has a market cap of 75.83M. Regarding current trading prices, CALZF is priced at $0.94, while IPDQF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas IPDQF's P/E ratio is -3.74. In terms of profitability, CALZF's ROE is +0.07%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, CALZF is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs SNZZF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, SNZZF has a market cap of 71.91M. Regarding current trading prices, CALZF is priced at $0.94, while SNZZF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas SNZZF's P/E ratio is -5.40. In terms of profitability, CALZF's ROE is +0.07%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, CALZF is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs RDGL Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, RDGL has a market cap of 58.98M. Regarding current trading prices, CALZF is priced at $0.94, while RDGL trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas RDGL's P/E ratio is -13.01. In terms of profitability, CALZF's ROE is +0.07%, compared to RDGL's ROE of -1.86%. Regarding short-term risk, CALZF is more volatile compared to RDGL. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs BLOZF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, BLOZF has a market cap of 48.38M. Regarding current trading prices, CALZF is priced at $0.94, while BLOZF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas BLOZF's P/E ratio is -21.01. In terms of profitability, CALZF's ROE is +0.07%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, CALZF is more volatile compared to BLOZF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs NVYTF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, NVYTF has a market cap of 38.00M. Regarding current trading prices, CALZF is priced at $0.94, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas NVYTF's P/E ratio is -0.78. In terms of profitability, CALZF's ROE is +0.07%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, CALZF is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs TLTFF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, TLTFF has a market cap of 34.24M. Regarding current trading prices, CALZF is priced at $0.94, while TLTFF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas TLTFF's P/E ratio is -13.82. In terms of profitability, CALZF's ROE is +0.07%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, CALZF is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs ELXMF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, ELXMF has a market cap of 28.41M. Regarding current trading prices, CALZF is priced at $0.94, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, CALZF's ROE is +0.07%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, CALZF is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs PYNKF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, PYNKF has a market cap of 24.77M. Regarding current trading prices, CALZF is priced at $0.94, while PYNKF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas PYNKF's P/E ratio is -1.47. In terms of profitability, CALZF's ROE is +0.07%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, CALZF is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs KBBTF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, KBBTF has a market cap of 24.10M. Regarding current trading prices, CALZF is priced at $0.94, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, CALZF's ROE is +0.07%, compared to KBBTF's ROE of N/A. Regarding short-term risk, CALZF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs EMITF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, EMITF has a market cap of 22.19M. Regarding current trading prices, CALZF is priced at $0.94, while EMITF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas EMITF's P/E ratio is -14.29. In terms of profitability, CALZF's ROE is +0.07%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, CALZF is more volatile compared to EMITF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs POSC Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, POSC has a market cap of 19.42M. Regarding current trading prices, CALZF is priced at $0.94, while POSC trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas POSC's P/E ratio is 0.32. In terms of profitability, CALZF's ROE is +0.07%, compared to POSC's ROE of +9.25%. Regarding short-term risk, CALZF is more volatile compared to POSC. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs ASAPF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, ASAPF has a market cap of 16.93M. Regarding current trading prices, CALZF is priced at $0.94, while ASAPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas ASAPF's P/E ratio is -21.92. In terms of profitability, CALZF's ROE is +0.07%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, CALZF is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs VPTDF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, VPTDF has a market cap of 16.18M. Regarding current trading prices, CALZF is priced at $0.94, while VPTDF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas VPTDF's P/E ratio is -4.96. In terms of profitability, CALZF's ROE is +0.07%, compared to VPTDF's ROE of +3.89%. Regarding short-term risk, CALZF is more volatile compared to VPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs MDXHF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, MDXHF has a market cap of 15.49M. Regarding current trading prices, CALZF is priced at $0.94, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, CALZF's ROE is +0.07%, compared to MDXHF's ROE of +0.39%. Regarding short-term risk, CALZF is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs TMDIF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, TMDIF has a market cap of 13.91M. Regarding current trading prices, CALZF is priced at $0.94, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, CALZF's ROE is +0.07%, compared to TMDIF's ROE of -1.06%. Regarding short-term risk, CALZF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs DIZTF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, DIZTF has a market cap of 13.69M. Regarding current trading prices, CALZF is priced at $0.94, while DIZTF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas DIZTF's P/E ratio is -5.67. In terms of profitability, CALZF's ROE is +0.07%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, CALZF is more volatile compared to DIZTF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs PLLWF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, PLLWF has a market cap of 13.28M. Regarding current trading prices, CALZF is priced at $0.94, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas PLLWF's P/E ratio is -0.37. In terms of profitability, CALZF's ROE is +0.07%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, CALZF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs RMSL Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, RMSL has a market cap of 12.90M. Regarding current trading prices, CALZF is priced at $0.94, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas RMSL's P/E ratio is 0.84. In terms of profitability, CALZF's ROE is +0.07%, compared to RMSL's ROE of -1.94%. Regarding short-term risk, CALZF is more volatile compared to RMSL. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs IMEXF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, IMEXF has a market cap of 11.66M. Regarding current trading prices, CALZF is priced at $0.94, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas IMEXF's P/E ratio is N/A. In terms of profitability, CALZF's ROE is +0.07%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, CALZF is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs NGMDF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, NGMDF has a market cap of 11.51M. Regarding current trading prices, CALZF is priced at $0.94, while NGMDF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas NGMDF's P/E ratio is -1.83. In terms of profitability, CALZF's ROE is +0.07%, compared to NGMDF's ROE of +2.16%. Regarding short-term risk, CALZF is more volatile compared to NGMDF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs ATBPF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, ATBPF has a market cap of 11.43M. Regarding current trading prices, CALZF is priced at $0.94, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, CALZF's ROE is +0.07%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, CALZF is more volatile compared to ATBPF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs LXXGF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, LXXGF has a market cap of 11.34M. Regarding current trading prices, CALZF is priced at $0.94, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, CALZF's ROE is +0.07%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, CALZF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs GTHP Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, GTHP has a market cap of 8.19M. Regarding current trading prices, CALZF is priced at $0.94, while GTHP trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas GTHP's P/E ratio is -2.10. In terms of profitability, CALZF's ROE is +0.07%, compared to GTHP's ROE of +0.56%. Regarding short-term risk, CALZF is more volatile compared to GTHP. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs VYCO Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, VYCO has a market cap of 6.64M. Regarding current trading prices, CALZF is priced at $0.94, while VYCO trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas VYCO's P/E ratio is -19.90. In terms of profitability, CALZF's ROE is +0.07%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, CALZF is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs MKEAF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, MKEAF has a market cap of 6.60M. Regarding current trading prices, CALZF is priced at $0.94, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, CALZF's ROE is +0.07%, compared to MKEAF's ROE of +0.60%. Regarding short-term risk, CALZF is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs IRME Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, IRME has a market cap of 5.88M. Regarding current trading prices, CALZF is priced at $0.94, while IRME trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas IRME's P/E ratio is -2.72. In terms of profitability, CALZF's ROE is +0.07%, compared to IRME's ROE of +506.40%. Regarding short-term risk, CALZF is more volatile compared to IRME. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs DTXMF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, DTXMF has a market cap of 5.69M. Regarding current trading prices, CALZF is priced at $0.94, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, CALZF's ROE is +0.07%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, CALZF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs TBRIF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, TBRIF has a market cap of 5.59M. Regarding current trading prices, CALZF is priced at $0.94, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas TBRIF's P/E ratio is -1.23. In terms of profitability, CALZF's ROE is +0.07%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, CALZF is less volatile compared to TBRIF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs QLIS Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, QLIS has a market cap of 5.45M. Regarding current trading prices, CALZF is priced at $0.94, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas QLIS's P/E ratio is 2.22. In terms of profitability, CALZF's ROE is +0.07%, compared to QLIS's ROE of -8.21%. Regarding short-term risk, CALZF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs RHNMF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, RHNMF has a market cap of 5.45M. Regarding current trading prices, CALZF is priced at $0.94, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, CALZF's ROE is +0.07%, compared to RHNMF's ROE of -2.48%. Regarding short-term risk, CALZF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs ADMT Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, ADMT has a market cap of 4.73M. Regarding current trading prices, CALZF is priced at $0.94, while ADMT trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas ADMT's P/E ratio is -7.00. In terms of profitability, CALZF's ROE is +0.07%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, CALZF is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs MICR Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, MICR has a market cap of 4.73M. Regarding current trading prices, CALZF is priced at $0.94, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas MICR's P/E ratio is -3.47. In terms of profitability, CALZF's ROE is +0.07%, compared to MICR's ROE of -0.25%. Regarding short-term risk, CALZF is less volatile compared to MICR. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs FZMD Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, FZMD has a market cap of 4.51M. Regarding current trading prices, CALZF is priced at $0.94, while FZMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas FZMD's P/E ratio is 1.22. In terms of profitability, CALZF's ROE is +0.07%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, CALZF is more volatile compared to FZMD. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs NUMD Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, NUMD has a market cap of 4.18M. Regarding current trading prices, CALZF is priced at $0.94, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas NUMD's P/E ratio is 5.00. In terms of profitability, CALZF's ROE is +0.07%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, CALZF is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs LBLTF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, LBLTF has a market cap of 4.07M. Regarding current trading prices, CALZF is priced at $0.94, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, CALZF's ROE is +0.07%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, CALZF is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs BIEL Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, BIEL has a market cap of 3.62M. Regarding current trading prices, CALZF is priced at $0.94, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas BIEL's P/E ratio is N/A. In terms of profitability, CALZF's ROE is +0.07%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, CALZF is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs VANIW Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, VANIW has a market cap of 3.36M. Regarding current trading prices, CALZF is priced at $0.94, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas VANIW's P/E ratio is N/A. In terms of profitability, CALZF's ROE is +0.07%, compared to VANIW's ROE of -1.06%. Regarding short-term risk, CALZF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs PMEDF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, PMEDF has a market cap of 2.25M. Regarding current trading prices, CALZF is priced at $0.94, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas PMEDF's P/E ratio is -1.50. In terms of profitability, CALZF's ROE is +0.07%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, CALZF is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs ALRTF Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, ALRTF has a market cap of 2.22M. Regarding current trading prices, CALZF is priced at $0.94, while ALRTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas ALRTF's P/E ratio is -0.12. In terms of profitability, CALZF's ROE is +0.07%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, CALZF is less volatile compared to ALRTF. This indicates potentially lower risk in terms of short-term price fluctuations for CALZF.
CALZF vs LLBO Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, LLBO has a market cap of 2.17M. Regarding current trading prices, CALZF is priced at $0.94, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas LLBO's P/E ratio is N/A. In terms of profitability, CALZF's ROE is +0.07%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, CALZF is more volatile compared to LLBO. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.
CALZF vs USAQ Comparison
CALZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CALZF stands at 650.77M. In comparison, USAQ has a market cap of 1.83M. Regarding current trading prices, CALZF is priced at $0.94, while USAQ trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CALZF currently has a P/E ratio of 94.20, whereas USAQ's P/E ratio is -5.41. In terms of profitability, CALZF's ROE is +0.07%, compared to USAQ's ROE of +0.61%. Regarding short-term risk, CALZF is more volatile compared to USAQ. This indicates potentially higher risk in terms of short-term price fluctuations for CALZF.